General
Preferred name
LEVOBUNOLOL HYDROCHLORIDE
Synonyms
(-) -Levobunolol hydrochloride ()
Levobunolol (hydrochloride) ()
l-Bunolol hydrochloride ()
W 7000A ()
W-7000A ()
Levobunolol hcl ()
Betagan ()
Akbeta ()
NSC-759158 ()
Levobunolol (hydrochloride) ()
P&D ID
PD045824
CAS
27912-14-7
Tags
natural product
drug
available
Drug Status
approved
Max Phase
Phase 4
Drug indication
Anti-Adrenergic (beta-receptor)
First approval
1985
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure
P&D probe-likeness score
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
5
Cayman Chemical Bioactives
ChEMBL Approved Drugs
ChEMBL Drugs
MedChem Express Bioactive Compound Library
Prestwick Chemical Library
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
19
Properties
(calculated by RDKit )
Molecular Weight
327.16
Hydrogen Bond Acceptors
4
Hydrogen Bond Donors
2
Rotatable Bonds
5
Ring Count
2
Aromatic Ring Count
1
cLogP
2.76
TPSA
58.56
Fraction CSP3
0.59
Chiral centers
1.0
Largest ring
6.0
QED
0.87
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
Pathway
GPCR/G protein
Neuronal Signaling
Target
Adrenergic Receptor
Source data
